| |
| |
|
| Insider
Information: |
Ogrady Brendan P. |
| Relationship: |
EVP, North America Com... |
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,868 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$207,855 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,868 |
|
|
| Total
Value |
$207,855 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
EVP, North America Com... |
2021-03-05 |
14,868 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-05 |
4 |
AS |
$10.54 |
$120,580 |
D/D |
(11,436) |
14,868 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-04 |
4 |
AS |
$10.57 |
$86,511 |
D/D |
(8,172) |
26,304 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,905 |
33,773 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-03 |
4 |
AS |
$10.86 |
$5,029 |
D/D |
(463) |
15,571 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,166 |
16,034 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-02 |
4 |
AS |
$10.85 |
$163,601 |
D/D |
(15,085) |
14,868 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-03-01 |
4 |
AS |
$10.83 |
$798,023 |
D/D |
(73,127) |
29,953 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,934 |
103,080 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,120 |
30,988 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
67,852 |
98,840 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2021-02-09 |
4 |
AS |
$12.69 |
$262,700 |
D/D |
(20,694) |
78,146 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2020-03-17 |
4 |
AS |
$7.16 |
$3,367 |
D/D |
(470) |
14,868 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2020-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,179 |
15,338 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2020-03-03 |
4 |
AS |
$11.37 |
$5,262 |
D/D |
(463) |
14,159 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,166 |
14,622 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2020-02-10 |
4 |
AS |
$12.27 |
$58,884 |
D/D |
(4,799) |
13,456 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2020-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,120 |
18,255 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-09-18 |
4 |
S |
$7.83 |
$3,869 |
D/D |
(494) |
2,135 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,241 |
2,629 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-03-18 |
4 |
S |
$16.63 |
$19,601 |
D/D |
(1,179) |
1,388 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,179 |
2,567 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-03-12 |
4 |
S |
$15.67 |
$11,568 |
D/D |
(738) |
1,388 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
738 |
2,126 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-03-04 |
4 |
S |
$16.88 |
$19,686 |
D/D |
(1,166) |
1,388 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
• – – |
2019-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,166 |
2,554 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
